AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 73 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $11,000 | -92.7% | 186,700 | -79.3% | 0.00% | – |
Q2 2022 | $151,000 | +31.3% | 900,247 | +267.7% | 0.00% | – |
Q1 2022 | $115,000 | -56.1% | 244,839 | -46.8% | 0.00% | – |
Q4 2021 | $262,000 | -63.6% | 460,299 | +6.2% | 0.00% | – |
Q3 2021 | $719,000 | -0.6% | 433,475 | +0.1% | 0.00% | – |
Q2 2021 | $723,000 | -44.8% | 433,057 | -44.1% | 0.00% | – |
Q1 2021 | $1,310,000 | +108.3% | 775,132 | +96.0% | 0.00% | – |
Q4 2020 | $629,000 | +229.3% | 395,541 | +97.4% | 0.00% | – |
Q3 2020 | $191,000 | +130.1% | 200,392 | +53.9% | 0.00% | – |
Q2 2020 | $83,000 | -27.2% | 130,232 | -52.2% | 0.00% | – |
Q1 2020 | $114,000 | +12.9% | 272,610 | +57.3% | 0.00% | – |
Q4 2019 | $101,000 | +21.7% | 173,303 | +3.5% | 0.00% | – |
Q3 2019 | $83,000 | +18.6% | 167,463 | -7.5% | 0.00% | – |
Q2 2019 | $70,000 | -27.1% | 180,978 | +5.9% | 0.00% | – |
Q1 2019 | $96,000 | -35.1% | 170,933 | -54.4% | 0.00% | – |
Q4 2018 | $148,000 | +43.7% | 375,081 | +85.1% | 0.00% | – |
Q3 2018 | $103,000 | -60.4% | 202,583 | +71.2% | 0.00% | – |
Q2 2018 | $260,000 | -68.1% | 118,354 | -50.7% | 0.00% | – |
Q1 2018 | $816,000 | +43.2% | 239,947 | +71.3% | 0.00% | – |
Q4 2017 | $570,000 | +1087.5% | 140,095 | +78.5% | 0.00% | – |
Q3 2017 | $48,000 | -17.2% | 78,504 | -28.7% | 0.00% | – |
Q2 2017 | $58,000 | +5.5% | 110,048 | +61.2% | 0.00% | – |
Q1 2017 | $55,000 | +89.7% | 68,266 | +115.4% | 0.00% | – |
Q4 2016 | $29,000 | +81.2% | 31,700 | +46.1% | 0.00% | – |
Q3 2016 | $16,000 | -76.1% | 21,700 | -58.3% | 0.00% | – |
Q2 2016 | $67,000 | -34.3% | 52,040 | +14.4% | 0.00% | – |
Q1 2016 | $102,000 | +137.2% | 45,487 | +268.1% | 0.00% | – |
Q4 2015 | $43,000 | -75.6% | 12,356 | -83.4% | 0.00% | – |
Q2 2015 | $176,000 | -56.4% | 74,468 | +38.7% | 0.00% | – |
Q1 2015 | $404,000 | +38.4% | 53,672 | -37.0% | 0.00% | – |
Q4 2014 | $292,000 | -32.4% | 85,153 | -30.5% | 0.00% | – |
Q3 2014 | $432,000 | -47.6% | 122,443 | +24.1% | 0.00% | -100.0% |
Q2 2014 | $824,000 | +91.6% | 98,691 | +45.6% | 0.00% | 0.0% |
Q1 2014 | $430,000 | +444.3% | 67,771 | +545.3% | 0.00% | – |
Q3 2013 | $79,000 | – | 10,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |